STAT News

JANUARY 20, 2023

In an attempt to tackle the root causes of inflated insulin prices, the state of California filed a lawsuit last week accusing drug manufacturers and pharmacy benefit managers of artificially and illegally jacking up the price of insulin. The sausage-making of how insulin is priced is not for the faint of heart.

Insulin 105

Insulin Pharmacy Manufacturing Drugs 105

Drug Channels

APRIL 26, 2022

In this issue: Green Monster : The 340B market hits new highs in 2021 Not-Free Agents : Big 340B profits for CVS, Walgreens, Express Scripts, et al Batter Up : Fixing the insulin market Pinch Hitters : Walgreens bets on robots Plus, Dr. Glaucomflecken helps UnitedHealthcare celebrate Doctors’ Day! d/b/a Drug Channels Institute.

Pharmacy 98

Pharmacy Insulin Doctors Doctor 98

STAT News

MARCH 27, 2023

The Ohio attorney general filed a lawsuit on Monday accusing three large pharmacy benefit managers of fixing prices for various medicines, the latest effort to scrutinize the controversial companies that occupy a crucial role in pharmaceutical pricing.

Pharmacy 111

Pharmacy Drugs Insulin Medicine 111

pharmaphorum

JANUARY 13, 2023

The ‘big three’ insulin producers Novo Nordisk, Eli Lilly, and Sanofi are being sued by the state of California for allegedly working together to set artificially inflated prices for their products. The suit follows legal action over insulin pricing taken by other states, including Arkansas , Kansas, Mississippi, and Minnesota.

Insulin 105

Insulin Manufacturing Production Drugs 105

XTalks

JULY 24, 2024

Amazon Pharmacy launched a pair of TV spots last month to showcase the ease of its drug delivery service for consumers. To save all the waiting, “all mom had to do was use Amazon Pharmacy and her meds would get delivered right to her door,” the son thinks to himself.

Pharmacy 78

Pharmacy Drug Delivery Drugs Insulin 78

Drug Channels

MARCH 28, 2023

This week, I’m rerunning some popular posts while I prepare for this Friday’s live video webinar: Discount Cards, Cost-Plus Pharmacies, and PBMs: Trends, Controversies, and Outlook. Growth in the number of excluded drugs slowed for the second year, due partly to the fact that so many drugs have already been dropped from PBMs’ formularies.

Insulin 98

Insulin Pharmacy Containment Drugs 98

Drug Channels

MAY 10, 2023

Yesterday’s reflections on Asembia’s Specialty Pharmacy Summit included a link to the general session slides. My portion of the deck included an updated mapping of vertical integration among insurers, PBMs, specialty pharmacies, and providers within U.S. drug channels. d/b/a Drug Channels Institute. Enjoy the artwork.

Pharmacy 98

Pharmacy Insulin Drugs 98

Drug Channels

JANUARY 10, 2023

For 2023, the three largest pharmacy benefit managers (PBMs)—Caremark (CVS Health), Express Scripts (Cigna), and OptumRx (United Health Group)—have again increased the number of drugs they exclude from their standard formularies. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc.

Insulin 98

Insulin Pharmacy Containment Drugs 98

Drug Channels

MARCH 21, 2023

Spring is here in sunny downtown Philadelphia, worldwide headquarters of Drug Channels. Join me for my new live video webinar, Discount Cards, Cost-Plus Pharmacies, and PBMs: Trends, Controversies, and Outlook , on March 31, 2023, from 12:00 p.m. d/b/a Drug Channels Institute. to 1:30 p.m. Click here to learn more and sign up.

Insulin 98

Insulin Drugs Pharmacy 98

Drug Channels

NOVEMBER 23, 2021

In this issue: The State of Specialty Pharmacy 2021 How health plans profit—and patients lose—from insulin A fantastic new analysis of the gross-to-net bubble Reconsidering Amazon P.S. Please join the nearly 13,000 consumers of my daily commentary and links to neat stuff at @DrugChannels on Twitter. d/b/a Drug Channels Institute.

Insulin 75

Insulin Pharmacy Drugs 75

XTalks

SEPTEMBER 23, 2020

Being hailed as the world’s shortest and thinnest needle for insulin injection, Droplet Micron has recently been introduced into the pen needle market by HTL (High Tech Lab)-STREFA, Inc. These are important feature innovations for those that depend on insulin injections. Droplet Micron is now available at local pharmacies.

Insulin 98

Insulin Marketing Drug Delivery Compliance 98

Drug Channels

NOVEMBER 23, 2021

In this issue: The State of Specialty Pharmacy 2021 How health plans profit—and patients lose—from insulin A fantastic new analysis of the gross-to-net bubble CVS acknowledges how its PBM profits from 340B Reconsidering Amazon P.S. Please join the nearly 13,000 consumers of my daily commentary and links to neat stuff at @DrugChannels on Twitter.

Insulin 75

Insulin Pharmacy Drugs 75

Drug Channels

NOVEMBER 22, 2021

In this issue: The State of Specialty Pharmacy 2021 How health plans profit—and patients lose—from insulin A fantastic new analysis of the gross-to-net bubble CVS acknowledges how its PBM profits from 340B Reconsidering Amazon Plus, the FDA preps you for Thursday with a regulatory soup review. d/b/a Drug Channels Institute.

Insulin 75

Insulin Pharmacy Drugs 75

Drug Channels

JANUARY 9, 2024

For 2024, the three largest pharmacy benefit managers (PBMs)—Caremark (CVS Health), Express Scripts (Cigna), and OptumRx (United Health Group)—have again each excluded 600 or more drugs from their standard formularies. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company.

Insulin 98

Insulin Pharmacy Drugs Production 98

BioSpace

JULY 11, 2024

The Federal Trade Commission plans to file lawsuits against the three largest pharmacy benefit managers over allegedly steering patients away from less expensive drugs, according to The Wall Street Journal.

Insulin 75

Insulin Pharmacy Drugs 75

XTalks

MARCH 17, 2025

Amylin, a hormone co-secreted with insulin, plays a key role in regulating appetite by enhancing leptins effects the hormone that signals fullness after eating. Petrelintide, Zealand Pharmas long-acting amylin analog, is currently in Phase II clinical development and is designed for once-weekly subcutaneous injections.

Hormones 59

Hormones Drugs Sales Insulin 59

STAT News

NOVEMBER 17, 2022

… UnitedHealth Group’s pharmacy benefits manager, OptumRx, will keep AbbVie’s Humira alongside up to three biosimilar medicines next year, Bloomberg News writes. in 2023, giving prescription drug plans a chance to pit different suppliers against one another for discounts. Optum Rx, which is the third-largest U.S.

Insulin 96

Insulin Pharmacy Sales Medicine 96

Pharmacy Checkers

NOVEMBER 19, 2020

Forgetting about the potential dangers to competition from corporate Leviathan Amazon, that it launched a new online pharmacy this week will certainly appeal to tens of millions of Americans. Prescription drugs are yet another thing you can get when you go to Amazon.com. market to lower drug price. Quick case in point.

Pharmacy 52

Pharmacy Insulin Branding Drugs 52

The Pharma Data

JULY 29, 2021

Food and Drug Administration approved the first interchangeable biosimilar insulin product, indicated to improve glycemic control in adults and pediatric patients with Type 1 diabetes mellitus and in adults with Type 2 diabetes mellitus. director of the Office of New Drugs in the FDA’s Center for Drug Evaluation and Research.

Insulin 52

Insulin Production FDA Approval Generic Drugs 52

Drug Channels

JANUARY 19, 2022

For 2022, the three largest pharmacy benefit managers (PBMs)—Caremark (CVS Health), Express Scripts (Cigna), and OptumRx (United Health Group)— increased the number of drugs they excluded from their standard formularies. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc.

Insulin 98

Insulin Pharmacy Containment Drugs 98

pharmaphorum

JANUARY 28, 2021

In fact, because biosimilar adoption has accelerated in recent years, studies show that the United States is on track to reduce drug costs by $100 billion over the next five years. One of these markets is the insulin market. Currently, more than seven million patients rely on insulin, and that number is growing each year.

Marketing 119

Marketing Insulin HR Production 119

Drug Channels

APRIL 20, 2022

For 2022, the three largest pharmacy benefit managers (PBMs)—Caremark (CVS Health), Express Scripts (Cigna), and OptumRx (United Health Group)— increased the number of drugs they excluded from their standard formularies. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc.

Insulin 98

Insulin Pharmacy Containment Drugs 98

Drug Channels

SEPTEMBER 2, 2020

I'm rerunning this post to provide context for manufacturers' recent actions regarding 340B contract pharmacies. Yesterday, Eli Lilly announced that its products can be dispensed only at covered entities and their child sites, but not via external pharmacies. d/b/a Drug Channels Institute. d/b/a Drug Channels Institute.

Pharmacy 52

Pharmacy Insulin Manufacturing Drugs 52

Drug Channels

NOVEMBER 23, 2021

In this issue: The State of Specialty Pharmacy 2021 How health plans profit—and patients lose—from insulin A fantastic new analysis of the gross-to-net bubble CVS acknowledges how its PBM profits from 340B Reconsidering Amazon P.S. Please join the nearly 13,000 consumers of my daily commentary and links to neat stuff at @DrugChannels on Twitter.

Insulin 40

Insulin Pharmacy Drugs 40

Drug Channels

APRIL 3, 2024

This week, I’m rerunning some popular posts while I prepare for Friday’s live video webinar: Drug Channel Implications of the Inflation Reduction Act. There are also unusual formulary developments for insulin products, many of which experienced massive list price cuts for 2024. Click here to see the original post from January 2024.

Insulin 52

Insulin Pharmacy Drugs Production 52

Drug Channels

MARCH 30, 2023

This week, I’m rerunning some popular posts while I prepare for tomorrow’s live video webinar: Discount Cards, Cost-Plus Pharmacies, and PBMs: Trends, Controversies, and Outlook. Our crazy drug channel led Amgen to launch both a high-list/high-rebate and a low-list/low-rebate version of the drug. d/b/a Drug Channels Institute.

Insulin 75

Insulin Pharmacy Drugs Sales 75

XTalks

JUNE 5, 2023

Ozempic and Wegovy, which contain the active ingredient semaglutide, were approved by the US Food and Drug Administration (FDA). GLP-1 stimulates insulin production, thus reducing blood glucose levels, and it interacts with the brain to suppress appetite and create a feeling of fullness. mg and 2.4 mg doses of Wegovy.

FDA Approval 98

FDA Approval Containment Drugs Pharmacy 98

XTalks

JANUARY 5, 2024

Eli Lilly launched LillyDirect this week, an online service that provides access to the company’s medicines, including its newly approved weight loss drug Zepbound (tirzepatide). Interestingly, the company’s blockbuster diabetes drug, Mounjaro (tirzepatide), is not available through the new digital service.

Drugs 59

Drugs Pharmacy Cosmetics Medicine 59

STAT News

NOVEMBER 18, 2022

Food and Drug Administration , CNN tells us. Diabetic patients will now have easier access to insulin after the FDA approved an Eli Lilly biosimilar as interchangeable with the biologic drug , Bloomberg News notes. Rezvoglar, The first therapy that delays the onset of type 1 diabetes received approval from the U.S.

Insulin 98

Insulin FDA Approval Production Pharmacy 98

Druggist

OCTOBER 4, 2020

Drug treatment can be used alongside lifestyle measures. Most of the drugs which are recommended in the symptomatic management of IBS can be purchased over the counter from pharmacies, supermarkets and online. IBS – drug therapy IBS medications are used for symptomatic management of the condition. Drugs to stop diarrhoea.

Containment 98

Containment Pharmacy Bacteria Sales 98

Drug Channels

OCTOBER 1, 2024

Last week, the Federal Trade Commission (FTC) released the redacted version of administrative complaint against the three largest pharmacy benefit managers (PBMs). Much of the FTC’s description of the drug channel aligns with my commentary. drug channel will limit the impact of this impressive breakthrough. Section V.E.

Insulin 40

Insulin Branding Production Pharmacy 40

XTalks

SEPTEMBER 20, 2023

SmithRx, a pharmacy benefits management (PBM) company, joined forces with TheracosBio to facilitate patients’ access to the newly approved type 2 diabetes medication, Brenzavvy (bexagliflozin), through the Mark Cuban Cost Plus Drug Company platform. ” What is SmithRx? ” What is SmithRx?

Pharmacy 64

Pharmacy Drugs Manufacturing Generic Drugs 64

XTalks

FEBRUARY 8, 2024

The top 15 diabetes drugs in 2023, according to 2022 sales data, reflect the current state of diabetes management and hint at the evolving needs and trends within this critical area of healthcare. Read on to learn more about the top 15 diabetes drugs in 2023, based on 2022 sales statistics. mL subcutaneous solution (2 mg/1.5

Sales 52

Sales Insulin FDA Approval Drugs 52

XTalks

FEBRUARY 8, 2021

In order to fact-check some of these misconceptions, the US Food and Drug Administration (FDA) recently hosted a webinar on biosimilar and interchangeable biological products to help healthcare professionals understand more about these treatment options. Biosimilars are the “generic” drugs of the biopharma world. What is a Biosimilar?

Production 78

Production Insulin Branding Generic Drugs 78

pharmaphorum

JANUARY 6, 2023

On 14th November 2022, Eli Lilly apparently wrote on its Twitter account, “We are excited to announce insulin is free now.” New drug launches were delayed. The concept is predicated on a simple idea: ensuring every patient who holds a prescription is able to enrol in their drug regimen and see it through to completion.

Manufacturing 105

Manufacturing Sales Insulin Drugs 105

FDA Law Blog

DECEMBER 3, 2023

Conditions for Coverage after January 1, 2025: Any manufacturer that wishes to have its applicable drugs covered under Medicare Part D after January 1, 2025 (“participating manufacturers”) must execute a Discount Program agreement with CMS by March 1, 2024. Non-applicable drugs (e.g.,

Manufacturing 105

Manufacturing Drugs Compliance Pharmacy 105

Drug Channels

DECEMBER 16, 2020

This week, I’m rerunning some popular posts while I prepare for this Friday’s video webinar: Drug Channels Outlook 2021. I expect manufacturers to escalate their challenges to the contract pharmacy elements of the program. I summarize issues with the role of contract pharmacies in the 340B Drug Pricing Program.

Pharmacy 40

Pharmacy Insulin Manufacturing Drugs 40